Hemostatic potential of recombinant von Willebrand factor and standard or pegylated extended half-life recombinant factor VIII on thrombus formation under high shear flow

Hiroaki Yaoi,Yasuaki Shida,Kenichi Ogiwara,Keiji Nogami
DOI: https://doi.org/10.1186/s12959-023-00569-1
2023-12-09
Thrombosis Journal
Abstract:Von Willebrand factor (VWF) and factor VIII (FVIII) complex play a pivotal role in hemostasis. A deficiency or defect of VWF causes von Willebrand disease (VWD). Recombinant (r)VWF product has proved to be effective for hemostatic treatment of VWD, but limited information is available on their role in moderating thrombus formation under flow condition. We aimed to assess thrombus formation in the presence of rVWF combined with rFVIII or pegylated-extended half-life rFVIII (peg-EHL-rFVIII) in VWD whole blood under high shear flow.
peripheral vascular disease,hematology
What problem does this paper attempt to address?